mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.01 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |